Work

A Blood Biomarker-guided Precision Medicine Approach for Individualized Neurodegenerative Disease Risk Reduction and Treatment: The Future of Preventive Neurology? (P7-3.016)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000208443

Authors: Kellyann Niotis, Christopher Janney, Shannon Helfman, Hollie Hristov, Nicholas Clute-Reinig, Danny Angerbauer, Corey Saperia, Sara Murray, John Westine, Alon Seifan, Juan Melendez-Herencia, Praveen Parthasarathy, Helena Colvee, Beth Lewis, Jessica Lakis, Philip Sisser, Jannatul Dishary, Maia Mosse, Diana Saville, Audree Rumberger, Michael McCullough, Richard Isaacson

Institutions: Institute for Neurodegenerative Diseases, Atria, Stanford Medicine, Stanford University, The Neuro Well, Stony Brook University, University of Miami, Florida Atlantic University

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409236106

FWCI: 3.087

Cites:

Cited by: 5

Related to: 10